Results

Total Results: 2,279 records

Showing results for "factor".

61. Comparative Effectiveness of Pharmacologic Therapies for the Management of Crohn’s Disease | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/crohns-disease/research-protocol
    December 01, 2019 - antibodies, monoclonal/adverse effects”[mh] OR “anti-inflammatory agents”[mh] OR ((“tumour necrosis factor … ”[tiab] OR “tumour necrosis factor-alpha”[tiab] OR “tumor necrosis factor”[tiab] OR “tumor necrosis factor-alpha … Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for … KQ = Key question NMA = network meta-analysis RCT = randomized control trial TNF = tumor necrosis factor … in children CD = Crohn’s disease; FDA = Food and Drug Administration; TNF = tumor necrosis factor

62. RENAL MASS AND LOCALIZED RENAL CANCER *the following questions are recommended to address the healthcare tests and/or treatments this program should consider: • What indicators can be used to predict malignancy and/or aggressiveness of… | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/renal-mass-and-localized-renal-cancer-the-following-questions-are-recommended-to-address-the-healthcare-tests-andor-treatments-this-program-should-consider-what-indicators-can-be-used-to-predict-malignancy-andor-aggressivene
    November 01, 2017 - or other measures) Blood and urine laboratory tests Biomarkers Pigment epithelium-derived factor … (PEDF) Vascular endothelial growth factor (VEGF) Carbonic anhydrase IX (CA-IX) KI-67 Proliferating … Hypertension is now also a well-established risk factor for renal cancer. … Studies have also identified tobacco use as a risk factor in the development of renal cancer, when compared

63. Oral Cancer | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/health-topics/oral-cancer
    Frequent sun exposure is also a risk factor for lip cancer.

64. Computerized Definitions Showed High Positive Predictive Values for Identifying Reasons for Hospitalizations in a Medicaid Population with Rheumatoid Arthritis | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/rheumatoid-arthritis-hospitalizations/research
    January 01, 2020 - for post marketing studies of medication safety and we are evaluating the safety of tumor necrosis factor … and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor … Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor … Anti-tumor necrosis factor alpha therapy and heart failure: what have we learned and where do we go from … opportunistic infections and other serious potential adverse events associated with tumor necrosis factor

65. Arthritis-Psoriatric Executive (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_executive.pdf
    April 01, 2012 - Effective Health Care infliximab) are also classified as antitumor necrosis factor (anti-TNF) drugs … component score; SF-36 = Medical Outcomes Study Short Form 36; SSZ = sulfasalazine; TNF = tumor necrosis factor … cohort studies with low strength of evidence indicated that the combination of an anti-tumor necrosis factor … Efficacy and tolerability of anti-tumour necrosis factor therapy in psoriatic arthritis patients: results … Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous

66. Quantitative Synthesis: Chapter 4. Quantifying, Testing, and Exploring Statistical Heterogeneity (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-4.pdf
    July 01, 2019 - meta-regression is also an option, and requires consideration of these factors as well (e.g., ≥10 studies per factor … Subgroup analysis • Subgroup analysis is a form of meta-regression with a categorical study-level factor … It is recommended to incorporate the subgroup factor into a meta-regression framework.20 − This enables … under consideration of low power associated with limited studies (i.e., <10 studies per study- level factor

67. A1C | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/health-topics/a1c
    Having prediabetes is a risk factor for getting type 2 diabetes.

68. Teen Violence | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/health-topics/teen-violence
    April 15, 2013 - An important risk factor for violence in teens is the behavior of their friends and classmates.

69. Observed Association Between Antidepressant Use and Pneumonia Risk Was Confounded by Comorbidity Measures (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/antidepressants-seniors-pneumonia_research.pdf
    May 01, 2008 - One major etiologic factor for pneumonia in the elderly is aspiration of oropharyngeal contents [3,4 … We then examined each potential confounding factor individually using a change-in-estimate criterion … In particular, we individually added each potential confounding factor to the minimally adjusted model … If any factor changed the OR of interest by ten percent or more, we considered it to be a confounding … factor and retained it in the “change-in-estimate” adjusted model.

70. Use of Natriuretic Peptide Measurement in the Management of Heart Failure | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/heart-failure-natriuretic-peptide/research-protocol
    December 01, 2019 - bnp1-32.mp. 6 bnp-32.mp. 7 bnp77-108.mp. 8 probnp.mp. 9 nt-probnp1-76.mp. 10 natriuretic factor … 9 bnp 77-108.tw. 10 probnp.tw. 11 nt-probnp1-76.tw. 12 nt-probnp 1-76.tw. 13 natriuretic factor … bnp 1-32.tw. 6 bnp-32.tw. 7 bnp77-108.tw. 8 probnp.tw. 9 nt-probnp1-76.tw. 10 natriuretic factor … bnp1-32.tw. 6 bnp-32.tw. 7 bnp77-108.tw. 8 probnp.tw. 9 nt-probnp1-76.tw. 10 natriuretic factor … Prognostic Factor Measurement The prognostic factor of interest is adequately measured

71. Blood | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/health-topics/blood
    July 22, 2024 - And your Rh factor could be important if you become pregnant - an incompatibility between your type

72. Bleeding Disorders | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/health-topics/bleeding-disorders
    February 01, 2012 - Review Archived June 1, 2010 Comparative Effectiveness of In-Hospital Use of Recombinant Factor

73. Disposition of Comments for Venous Thromboembolism Prophylaxis in Orthopedic Surgery (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_disposition-comments.pdf
    March 01, 2012 - I would recommend NOT using FXI as the abbreviation for Factor Xa inhbitors are there are indeed Factor … Rivaroxaban binds to factor Xa in the prothrombinase complex, clot-bound factor Xa, and free factor … Effect of BAY 59-7939–a novel, oral, direct factor Xa inhibitor–on clot- bound factor Xa activity in … Compliance for the mechanical modalities remains a factor. … Factor Xa Inhibitors, rivaroxaban and apixaban.

74. Computerized Definitions Showed High Positive Predictive Values for Identifying Reasons for Hospitalizations in a Medicaid Population with Rheumatoid Arthritis (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-hospitalizations_research.pdf
    October 01, 2008 - for post marketing studies of medication safety and we are evaluating the safety of tumor necrosis factor … bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor … Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor … Anti-tumor necrosis factor alpha therapy and heart failure: what have we learned and where do we go … opportunistic infections and other serious potential adverse events associated with tumor necrosis factor

75. Head and Neck Cancer | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/health-topics/head-and-neck-cancer
    September 02, 2015 - Infection with HPV is a risk factor for some head and neck cancers.

76. Mastectomy | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/health-topics/mastectomy
    June 18, 2020 - Reconstruction After Mastectomy Research Report September 13, 2012 Data Points #15: Prognostic factor

77. Rheumatoid-Arthritis-Medicine Surveillance (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_surveillance.pdf
    March 01, 2013 - Oral DMARDs Anti-­‐tumor  necrosis  factor  drugs  vs.   … Oral DMARDs Anti-tumor necrosis factor drugs vs. … Oral DMARDs Anti-tumor necrosis factor drugs vs. … Oral DMARDs Anti-tumor necrosis factor drugs vs. … Oral DMARDs Anti-tumor necrosis factor drugs vs.

78. Rheumatoid-Arthritis-Medicine Surveillance (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_surveillance.pdf
    March 01, 2013 - Oral DMARDs Anti-­‐tumor  necrosis  factor  drugs  vs.   … Oral DMARDs Anti-tumor necrosis factor drugs vs. … Oral DMARDs Anti-tumor necrosis factor drugs vs. … Oral DMARDs Anti-tumor necrosis factor drugs vs. … Oral DMARDs Anti-tumor necrosis factor drugs vs.

79. Blood-Clots-Hip-Knee-Surgery Executive (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_executive.pdf
    March 01, 2012 - Classes include oral antiplatelet agents, injectable LMWHs, injectable UFH, injectable or oral factor … factor Xa inhibitors vs. … LMWHs may be inferior to factor Xa inhibitors in terms of any, proximal, and distal DVTs but have a … As such, it is likely inferior to factor Xa inhibitors in the balance of benefits and harms as well … VKAs but higher bleeding; worse efficacy vs. factor Xa inhibitors but lower bleeding).

80. Evidence Report on the (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/crohns-disease_research-protocol.pdf
    September 01, 2010 - antibodies, monoclonal/adverse effects”[mh] OR “anti-inflammatory agents”[mh] OR ((“tumour necrosis factor … ”[tiab] OR “tumour necrosis factor-alpha”[tiab] OR “tumor necrosis factor”[tiab] OR “tumor necrosis … factor-alpha”[tiab] OR TNF[tiab] OR TNF- alpha[tiab]) AND (antibod*[tiab] OR antagonist[tiab] OR antagonists … Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy … KQ = Key question NMA = network meta-analysis RCT = randomized control trial TNF = tumor necrosis factor